Benjamin P. Saylor on Muck Rack

Benjamin P. Saylor

Verified
North Olmsted
As seen in: Urology Times, NewsBreak, HCP Live, Modern Medicine, CURE Magazine, Contemporary OB/GYN, OncLive, Contemporary Pediatrics, Diagnostic Imaging, Targeted Oncology, Oncology Nursing News
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Benjamin P.

Contact Benjamin P., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

SMFM in midst of first annual High-Risk Pregnancy Awareness Week

|
By Joshua Fitch , Benjamin P. Saylor , Melissa Loseke
| Contemporary OB/GYN
The Society for Maternal-Fetal Medicine (SMFM) is currently observing its first annual High-Risk Pregnancy Awareness Week (HRPAW), which runs from June 1–8.
Open in Who Shared Issue with article?

Top 5 pediatric health headlines you missed in May 2026

|
By Morgan Ebert , Benjamin P. Saylor , Julie Khlevner
| Contemporary Pediatrics
In this monthly recap, Contemporary Pediatrics reviews the most significant developments shaping pediatric practice and public health. Click each title below for full coverage. 1. FDA approves inhaled insulin Afrezza for children and adolescents with diabetes On May 29, the FDA approved Afrezza for children and adolescents aged 6 years and older with diabetes, making it the first rapid-acting inhaled insulin available for pediatric patients requiring mealtime insulin.
Open in Who Shared Issue with article?

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

|
By Joshua Fitch , Benjamin P. Saylor , Melissa Loseke
| Contemporary OB/GYN
Nearly 18 million middle-aged women in the United States are estimated to be overdue for at least 1 recommended cancer screening test, according to a cross-sectional study published in JAMA Women's Health. The findings highlight persistent and widespread gaps in breast, cervical, and colorectal cancer screening uptake among women aged 45 to 6, an age group for which all 3 screenings are currently recommended, and identify access-related factors as key drivers of incomplete screening.
Open in Who Shared Issue with article?
See all 909 licensed articles (936 Total)

Actions

Share this page

Get in touch with Benjamin P.

Contact Benjamin P., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified